Literature DB >> 12926582

Comparison of directly elicited preferences to preferences derived from the SF-36 in adults with asthma.

Todd A Lee1, William Hollingworth, Sean D Sullivan.   

Abstract

INTRODUCTION: Algorithms have been developed that estimate preferences from the Short Form 36 (SF-36). The objective of this study was to compare SF-36-derived preferences to directly elicited preferences.
METHODS: The authors used data from a clinical trial of adult asthmatics to derive preferences from the SF36 and compare those to visual analog scale (VAS) values and the Asthma Quality-of-Life Questionnaire (AQLQ).
RESULTS: The differences between VAS and derived preferences ranged from -0.066 to 0.024 at baseline and 0.006 to 0.107 at the end of follow-up. All measures improved from baseline (P < 0.001); however, derived preferences underestimated change (0.066 to 0.131) compared to the VAS (0.173) (P < 0.001), which could affect economic evaluations. Correlations between preferences and the AQLQ ranged from 0.56 to 0.70 at baseline (P < 0.001) and 0.53 to 0.70 for changes from baseline (P < 0.001).
CONCLUSIONS: The derivation methods produce valid and responsive measures of patient preference. However, derived preferences differ from one another and directly elicited VAS preferences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926582     DOI: 10.1177/0272989X03256009

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  10 in total

1.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

Authors:  J T Langfitt; B G Vickrey; M P McDermott; S Messing; A T Berg; S S Spencer; M R Sperling; C W Bazil; S Shinnar
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

3.  Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores.

Authors:  Mark C Hornbrook; Christopher S Wendel; Stephen Joel Coons; Marcia Grant; Lisa J Herrinton; M Jane Mohler; Carol M Baldwin; Carmit K McMullen; Sylvan B Green; Andrea Altschuler; Susan M Rawl; Robert S Krouse
Journal:  Med Care       Date:  2011-03       Impact factor: 2.983

4.  Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire.

Authors:  C M McDonough; M R Grove; A D Elledge; A N A Tosteson
Journal:  Osteoporos Int       Date:  2011-04-12       Impact factor: 4.507

5.  Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients.

Authors:  David Feeny; Lieling Wu; Ken Eng
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

6.  Predicting SF-6D utility scores from the neck disability index and numeric rating scales for neck and arm pain.

Authors:  Leah Y Carreon; Paul A Anderson; Christine M McDonough; Mladen Djurasovic; Steven D Glassman
Journal:  Spine (Phila Pa 1976)       Date:  2011-03-15       Impact factor: 3.468

7.  Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies.

Authors:  Ling-Hsiang Chuang; Paul Kind
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Predicting SF-6D utility scores from the Oswestry disability index and numeric rating scales for back and leg pain.

Authors:  Leah Y Carreon; Steven D Glassman; Christine M McDonough; Raja Rampersaud; Sigurd Berven; Michael Shainline
Journal:  Spine (Phila Pa 1976)       Date:  2009-09-01       Impact factor: 3.468

9.  Health related quality of life in sickle cell patients: the PiSCES project.

Authors:  Donna K McClish; Lynne T Penberthy; Viktor E Bovbjerg; John D Roberts; Imoigele P Aisiku; James L Levenson; Susan D Roseff; Wally R Smith
Journal:  Health Qual Life Outcomes       Date:  2005-08-29       Impact factor: 3.186

10.  Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?

Authors:  A Simon Pickard; Zhixiao Wang; Surrey M Walton; Todd A Lee
Journal:  Health Qual Life Outcomes       Date:  2005-03-04       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.